Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification

Annual HCC risk varies greatly in patients with cirrhosis ranging from as little as5%. Although this variability is well recognized, few models exist to estimate HCC risk in patients with cirrhosis and none are commonly used. Liver societies recommend the same screening strategy (abdominal ultrasonography every 6 months with or without concomitant serum AFP) irrespective of HCC risk[1-3]. Studies show poor compliance with these screening recommendations[4,5]. Stratification of HCC risk in patients with cirrhosis into low (e.g.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Source Type: research